sublingual immunotherapy


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

sublingual immunotherapy

Abbreviation: SLIT
Allergen desensitization in which the antigen is administered in droplet form under the tongue instead of being injected subcutaneously. SLIT is a relatively safe form of immunotherapy and is often used at home instead of in a medical office, several times a week.

Patient care

Adverse effects include oral itching or swelling and gastrointestinal upset. The incidence of systemic side effects may be reduced with SLIT as opposed to immunotherapy by subcutaneous injection.

See also: immunotherapy
References in periodicals archive ?
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Immune mechanisms of allergen-specific sublingual immunotherapy.
Systematic reviews of sublingual immunotherapy (SLIT).
9 patients who took the sublingual immunotherapy tablets rather than placebo daily for 3 years, one additional patient experienced 'well days' for the entire grass pollen season during those 3 years, along with the next 2 years of no treatment.
Subcutaneous immunotherapy is clearly superior to sublingual immunotherapy.
Nelson has just completed a review of 104 published studies of sublingual immunotherapy, about half of which were double blind and placebo controlled.
HOUSTON -- Sublingual immunotherapy, or SLIT, long used by clinicians worldwide, is newly approved for use in the United States, and practice guidelines have yet to be published for U.
HOUSTON--Whether atopic dermatitis should be treated with allergen immunotherapy is still a matter of debate, as high-quality trial evidence remains scant, but clinical practice is starting to recognize the potential use of subcutaneous and sublingual immunotherapy for certain presentations of the disease.
The safety of sublingual immunotherapy with one or multiple pollen allergens in children.
Sublingual immunotherapy, widely used for allergy control and prevention in Europe and South America, is starting to draw the attention of mainstream allergists in the United States, Dr.